Home Contact Center Add this

Debiopharm Group™

A bridge between the discovery of new molecules and patient access

Debiopharm Group is a Swiss-headquartered global biopharmaceutical group including five companies active in the life science areas of drug development, GMP manufacturing of proprietary drugs, diagnostic tools and investment management. The group in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide.

Besides drug development, Debiopharm has recently developed in-house skills in the field of companion diagnostics with a view to benefit from the key opportunities in personalized medicine.

Debiopharm Group independently funds the worldwide development of all of its products while providing expertise in all areas.


Thierry Mauvernay

Thierry Mauvernay

President & Delegate of the Board, Debiopharm Group™

Mr Mauvernay received his Master of Science in Economics in 1975. He then obtained a degree (MBA) from the 'Institut d'Administration des Entreprises’ and a DESS in Marketing (Master II Degree) in Clermont-Ferrand, France in 1976. In 1978, he founded an international cosmetics company, which he sold in 1998 but continued to manage until July 2001, when he joined Debiopharm International SA as Executive Vice President with direct responsibilities for the Finance and Administration Department. In 2006, Mr Mauvernay handed over his operational activities within Debiopharm International SA and has since been focusing on the administration, finance and strategy of Debiopharm Group. Since 2012, Mr Mauvernay is the Delegate of the Board of Debiopharm Group.

Debiopharm Group™

Forum "après-demain"
Chemin Messidor 5-7
Case postale 5911
CH-1002 Lausanne

Tel. +41 (0)21 321 0111
Fax. +41 (0)21 321 0169